Recent studies have identified a dominant subclone in patients with recurrent osteosarcoma with a novel TP53-KPNA3 translocation and deletion of the wild-type TP53 allele, suggesting its prognostic significance (16). The gene discussed is TP53; the disease is osteosarcoma.